Insights and recommendations on how AI, Gen AI, and automation can present significant opportunities to help healthcare payers reduce costs and improve medical loss ratios as economic pressures continue to rise.

According to the Gartner® Predicts 2025: AI Reshapes How U.S. Healthcare Payer CIOs Do Business report, “economic pressures, demands for technology advancement, and the proliferation of AI and Gen AI are forcing payers to reevaluate and reshape how they do business.”
That is why the Gartner report notes, “As payers look to new technologies like AI and generative AI (Gen AI) to optimize their business and increase employee effectiveness, investments in culture and employee experience (EX) to help drive adoption and change.”
Get the details healthcare payers need to prepare for investments in AI and GenAI that will optimize their business and reduce costs.
Get your complimentary copy of the Gartner® Predicts 2025: AI Reshapes How U.S. Healthcare Payer CIOs Do Business report thought leadership report to learn more about the strategic planning assumptions:
- By 2027, GenAI solutions will reduce administrative costs by 30% for most healthcare insurers with more than one million members.
- By 2027, 25% of payer organizations’ legacy applications will be replaced, stemming from an increased reliance on industry cloud platforms spurred by rapid adoption of AI.
- By 2027, 20% of payers will yield a faster ROI in AI investments by prioritizing and investing in organizational culture and employee experience – outpacing the revenue of their competitors.”
Get Your Complimentary Copy of the Gartner® Report.
Gartner, Predicts 2025: AI Reshapes How U.S. Healthcare Payer CIOs Do Business, by Faith Adams, Austynn Rubank, et al., 16 January 2025. This graphic was published by Gartner, Inc. as part of a larger research document and should be evaluated in the context of the entire document. The Gartner document is available upon request from NLP Logix. GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.